{"id":9288,"date":"2016-08-29T23:24:11","date_gmt":"2016-08-30T03:24:11","guid":{"rendered":"http:\/\/www.wvih.com\/wp1\/?p=9288"},"modified":"2016-09-09T23:18:26","modified_gmt":"2016-09-10T03:18:26","slug":"mylan-makes-generic-edipen","status":"publish","type":"post","link":"https:\/\/www.wvih.com\/wp1\/index.php\/2016\/08\/29\/mylan-makes-generic-edipen\/","title":{"rendered":"Mylan Makes Generic Edipen"},"content":{"rendered":"

\"EpiPen\"
\nThe drug company Mylan says it’s making a generic version of its EpiPen, which will be about half the price of the brand name.<\/p>\n

Mylan’s recent hike of an EpiPen double pack to $608 brought about much criticism, and last week Mylan announced a $300 savings card and a revised patient assistance program. The company says those offerings will continue.
\nSource: AP<\/p>\n","protected":false},"excerpt":{"rendered":"

The drug company Mylan says it’s making a generic version of its EpiPen, which will be about half the price of the brand name.<\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[59],"tags":[],"class_list":["post-9288","post","type-post","status-publish","format-standard","category-news","entry","has-post-thumbnail"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6aKAp-2pO","jetpack-related-posts":[],"jetpack_likes_enabled":true,"publishpress_future_action":{"enabled":false,"date":"2026-06-04 18:06:51","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/posts\/9288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/comments?post=9288"}],"version-history":[{"count":1,"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/posts\/9288\/revisions"}],"predecessor-version":[{"id":9292,"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/posts\/9288\/revisions\/9292"}],"wp:attachment":[{"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/media?parent=9288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/categories?post=9288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wvih.com\/wp1\/index.php\/wp-json\/wp\/v2\/tags?post=9288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}